Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes
- Author
- CARVAJAL-GONZALEZ, Alexander1 ; LEITE, M. Isabel1 ; PRESS, Raomand5 ; LUNN, Michael P6 ; MING LIM1 ; MADDISON, Paul7 ; MEINCK, H.-M2 ; VANDENBERGHE, Wim8 ; VINCENT, Angela1 ; WATERS, Patrick1 ; WOODHALL, Mark1 ; COUTINHO, Ester1 ; BALINT, Bettina2 ; BETHAN LANG1 ; PETTINGILL, Philippa1 ; CARR, Aisling3 ; SHEERIN, Una-Marie4
[1] Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom
[2] Department of Neurology, INF 400, 69120 Heidelberg, Germany
[3] Department of Clinical Neurology, Royal Victoria Hospital, Belfast, Northern Ireland, BT12 6BA, Ireland
[4] Department of Clinical Neurosciences, Charing Cross Hospital, Imperial College, London, United Kingdom
[5] Clinical Neuroscience, Karolinska Institute, Department of Neurology, Karolinska University Hospital Huddinge, Stockholm, Sweden
[6] Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, United Kingdom
[7] Department of Clinical Neurology, Queen's Medical Centre, Nottingham, NG7 2UH, United Kingdom
[8] Department of Neurology, University Hospitals Leuven; Department of Neurosciences, KU Leuven, Leuven, Belgium - Source
Brain. 2014, Vol 137, pp 2178-2192, 15 p ; 8 ; ref : 1 p.1/4
- Publisher
- Oxford University Press, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- autoantibody autoimmune encephalitis glycine receptor progressive encephalomyelitis with rigidity and myoclonus stiff person syndrome
- Keyword (fr)
- Autoanticorps Autoimmunité Encéphalite Encéphalomyélite Myoclonie Pathologie du système nerveux Pronostic Récepteur glycine Syndrome de l'homme raide Mouvement involontaire Pathologie de l'encéphale Pathologie de la moelle épinière Pathologie du muscle strié Pathologie du système nerveux central Trouble neurologique
- Keyword (en)
- Autoantibody Autoimmunity Encephalitis Encephalomyelitis Myoclonus Nervous system diseases Prognosis Glycine receptor Stiff man syndrome Involuntary movement Cerebral disorder Spinal cord disease Striated muscle disease Central nervous system disease Neurological disorder
- Keyword (es)
- Autoanticuerpo Autoinmunidad Encefalitis Encéfalomielitis Mioclonia Sistema nervioso patología Pronóstico Receptor glicina Hombre rígido síndrome Movimiento involuntario Encéfalo patología Médula espinal patología Músculo estriado patología Sistema nervosio central patología Trastorno neurológico
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17A Nervous system (semeiology, syndromes) / 002B17A01 Nervous system as a whole
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17A Nervous system (semeiology, syndromes) / 002B17A07 Cerebrospinal fluid. Meninges. Spinal cord
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17F Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17H Diseases of striated muscles. Neuromuscular diseases
- Discipline
- Neurology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 28608823
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1093/brain/awu142 
https://dx.doi.org/10.1093/brain/awu142
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1093\/brain\/awu142\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:106:\"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Brain\";s:9:\"\u0000*\u0000stitle\";s:5:\"Brain\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"137\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:4:\"2178\";s:8:\"\u0000*\u0000epage\";s:4:\"2192\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-8950\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:17:\"CARVAJAL-GONZALEZ\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Alexander\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:16:\"LEITE, M. Isabel\";i:1;s:14:\"PRESS, Raomand\";i:2;s:15:\"LUNN, Michael P\";i:3;s:8:\"MING LIM\";i:4;s:14:\"MADDISON, Paul\";i:5;s:12:\"MEINCK, H.-M\";i:6;s:17:\"VANDENBERGHE, Wim\";i:7;s:15:\"VINCENT, Angela\";i:8;s:15:\"WATERS, Patrick\";i:9;s:14:\"WOODHALL, Mark\";i:10;s:15:\"COUTINHO, Ester\";i:11;s:15:\"BALINT, Bettina\";i:12;s:11:\"BETHAN LANG\";i:13;s:20:\"PETTINGILL, Philippa\";i:14;s:13:\"CARR, Aisling\";i:15;s:18:\"SHEERIN, Una-Marie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:1:\"8\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:106:\"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"15\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1093\/brain\/awu142\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:106:\"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Brain\";s:9:\"\u0000*\u0000stitle\";s:5:\"Brain\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"137\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:4:\"2178\";s:8:\"\u0000*\u0000epage\";s:4:\"2192\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-8950\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:17:\"CARVAJAL-GONZALEZ\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Alexander\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:16:\"LEITE, M. Isabel\";i:1;s:14:\"PRESS, Raomand\";i:2;s:15:\"LUNN, Michael P\";i:3;s:8:\"MING LIM\";i:4;s:14:\"MADDISON, Paul\";i:5;s:12:\"MEINCK, H.-M\";i:6;s:17:\"VANDENBERGHE, Wim\";i:7;s:15:\"VINCENT, Angela\";i:8;s:15:\"WATERS, Patrick\";i:9;s:14:\"WOODHALL, Mark\";i:10;s:15:\"COUTINHO, Ester\";i:11;s:15:\"BALINT, Bettina\";i:12;s:11:\"BETHAN LANG\";i:13;s:20:\"PETTINGILL, Philippa\";i:14;s:13:\"CARR, Aisling\";i:15;s:18:\"SHEERIN, Una-Marie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:1:\"8\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:106:\"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"15\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:20:\"10.1093\/brain\/awu142\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1093\/brain\/awu142\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:106:\"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Brain\";s:9:\"\u0000*\u0000stitle\";s:5:\"Brain\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"137\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:4:\"2178\";s:8:\"\u0000*\u0000epage\";s:4:\"2192\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-8950\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:17:\"CARVAJAL-GONZALEZ\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Alexander\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:16:\"LEITE, M. Isabel\";i:1;s:14:\"PRESS, Raomand\";i:2;s:15:\"LUNN, Michael P\";i:3;s:8:\"MING LIM\";i:4;s:14:\"MADDISON, Paul\";i:5;s:12:\"MEINCK, H.-M\";i:6;s:17:\"VANDENBERGHE, Wim\";i:7;s:15:\"VINCENT, Angela\";i:8;s:15:\"WATERS, Patrick\";i:9;s:14:\"WOODHALL, Mark\";i:10;s:15:\"COUTINHO, Ester\";i:11;s:15:\"BALINT, Bettina\";i:12;s:11:\"BETHAN LANG\";i:13;s:20:\"PETTINGILL, Philippa\";i:14;s:13:\"CARR, Aisling\";i:15;s:18:\"SHEERIN, Una-Marie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:1:\"8\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:106:\"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"15\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1093\/brain\/awu142\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:106:\"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Brain\";s:9:\"\u0000*\u0000stitle\";s:5:\"Brain\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"137\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:4:\"2178\";s:8:\"\u0000*\u0000epage\";s:4:\"2192\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-8950\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:17:\"CARVAJAL-GONZALEZ\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Alexander\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:16:\"LEITE, M. Isabel\";i:1;s:14:\"PRESS, Raomand\";i:2;s:15:\"LUNN, Michael P\";i:3;s:8:\"MING LIM\";i:4;s:14:\"MADDISON, Paul\";i:5;s:12:\"MEINCK, H.-M\";i:6;s:17:\"VANDENBERGHE, Wim\";i:7;s:15:\"VINCENT, Angela\";i:8;s:15:\"WATERS, Patrick\";i:9;s:14:\"WOODHALL, Mark\";i:10;s:15:\"COUTINHO, Ester\";i:11;s:15:\"BALINT, Bettina\";i:12;s:11:\"BETHAN LANG\";i:13;s:20:\"PETTINGILL, Philippa\";i:14;s:13:\"CARR, Aisling\";i:15;s:18:\"SHEERIN, Una-Marie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:1:\"8\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:106:\"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"15\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1093\/brain\/awu142\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:106:\"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Brain\";s:9:\"\u0000*\u0000stitle\";s:5:\"Brain\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"137\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:4:\"2178\";s:8:\"\u0000*\u0000epage\";s:4:\"2192\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-8950\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:17:\"CARVAJAL-GONZALEZ\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Alexander\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:16:\"LEITE, M. Isabel\";i:1;s:14:\"PRESS, Raomand\";i:2;s:15:\"LUNN, Michael P\";i:3;s:8:\"MING LIM\";i:4;s:14:\"MADDISON, Paul\";i:5;s:12:\"MEINCK, H.-M\";i:6;s:17:\"VANDENBERGHE, Wim\";i:7;s:15:\"VINCENT, Angela\";i:8;s:15:\"WATERS, Patrick\";i:9;s:14:\"WOODHALL, Mark\";i:10;s:15:\"COUTINHO, Ester\";i:11;s:15:\"BALINT, Bettina\";i:12;s:11:\"BETHAN LANG\";i:13;s:20:\"PETTINGILL, Philippa\";i:14;s:13:\"CARR, Aisling\";i:15;s:18:\"SHEERIN, Una-Marie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:1:\"8\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:106:\"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"15\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
